Dow Down1.40% Nasdaq Down1.59%

Biogen Idec Inc. (BIIB)

323.50 7.31(2.21%) Oct 1, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:376.76
Median Target:376.00
High Target:474.00
Low Target:262.00
No. of Brokers:21

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 30, 2013FBR CapitalInitiated Mkt Perform
Dec 18, 2012Canaccord GenuityInitiated Hold
Oct 5, 2012OppenheimerDowngradeOutperformPerform
Sep 10, 2012UBSDowngradeBuyNeutral
Dec 9, 2011Barclays CapitalInitiated Overweight
Sep 9, 2011UBSUpgradeNeutralBuy
Aug 18, 2011OppenheimerUpgradePerformOutperform
Jun 21, 2011Deutsche BankUpgradeHoldBuy
Apr 15, 2011MP AdvisorsUpgradeMarket PerformOutperform
Feb 24, 2011RBC Capital MktsUpgradeSector PerformOutperform

More Upgrades & Downgrades for BIIB

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy5467

Data provided by Thomson/First Call

Currency in USD.